Primary immune deficiencies - principles of care

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Chapel, Helen ^a   Prevot, Johan ^b   Gaspar, Hubert Bobby ^c   Español, Teresa ^d   Bonilla, Francisco A ^e   Solis, Leire ^b   Drabwell, Josina ^b   Ballow, M ^f   Brown, L ^g   Costa Carvalho, B T ^h   Edgar, J D ⁱ   Egner, W ^j   Ehl, S ^k   Esser, M ^l   Gardulf, A ^m   Gennery, A ⁿ   Kerr, J ^o   Kinnon, C ^g   Lau, Y L ^p   Litzman, J ^q   Longhurst, H J ^r   Mahlaoui, N ^s   Orange, J S ^t   Picard, C ^s   Puck, J ^u   Sanchez Ramon S ^v   Schmidt, R E ^w   Singh, S ^x   Spickett, G ⁿ   Sullivan, K ^y   Symes, A ^z   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b International Patient Organisation for Primary Immunodeficiencies (IPOPI)   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HARVARD MEDICAL SCHOOL   (United States)

^f CHILDREN S HOSPITAL OF BUFFALO   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ United Kingdom Primary Immunodeficiency Network   (United Kingdom)

^j British Society for Immunology   (United Kingdom)

^k Microbiome Core Facility   (Germany)

^l STELLENBOSCH UNIVERSITY   (South Africa)

^m KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o PAUL EHRLICH INSTITUT   (Germany)

^p UNIVERSITY OF HONG KONG   (Hong Kong)

^q ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^r BARTS HEALTH NHS TRUST   (United Kingdom)

^s HÔPITAL NECKER ENFANTS MALADES   (France)

^t BAYLOR COLLEGE OF MEDICINE   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^w HANNOVER MEDICAL SCHOOL   (Germany)

^x POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^y CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^z ROYAL FREE HOSPITAL   (United Kingdom)

more..

Author keywords

Awareness; Diagnosis; Management; Primary immunodeficiencies; Treatments; Worldwide

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; DECISION MAKING; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; GENE THERAPY; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CENTER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INSURANCE; MEDICAL SPECIALIST; NEWBORN SCREENING; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIMARY IMMUNE DEFICIENCY; PSYCHOTHERAPY; REGISTER; SEVERE COMBINED IMMUNODEFICIENCY; SUBSTITUTION THERAPY; VACCINATION;

EID: 84919468910     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00627     Document Type: Article

References (53)

1. Al-Herz W, Bousfiha A, Casanova J-L, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2014) 5:54. doi: 10.3389/fimmu.2011.00054
2. Maggadottir SM, Sullivan KE. The intersection of immune deficiency and autoimmunity. Curr Opin Rheumatol (2014) 26(5):570-8. doi:10.1097/BOR.0000000000000091
3. Blore J, Haeney M. Primary antibody deficiency and diagnostic delay. Br Med J (1989) 298:516-7. doi:10.1136/bmj.298.6672.516
4. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol (1989) 9:22-33. doi:10.1007/BF00917124
5. De Vries E, Driessen G. Primary immunodeficiencies in children: a diagnostic challenge. Eur J Pediatr (2011) 170(2):169-77. doi:10.1007/s00431-010-1358-5
6. Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med (2014) 371:434-46. doi:10.1056/NEJMoa1401177
7. Touzot F, Hacein-Bey-Abina S, Fischer A, Cavazzana M. Gene therapy for inherited immunodeficiency. Expert Opin Biol Ther (2014) 14(6):789-98. doi:10.1517/14712598.2014.895811
8. De Vries E; European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol (2012) 167:108-19. doi:10.1111/j.1365-2249.2011.04461.x
9. Hernandez-Trujillo HS, Chapel H, Lo Re V III, Notarangelo LD, Gathmann B, Grimbacher B, et al. Comparison of American and European practices in the management of patients with primary immunodeficiencies. Clin Exp Immunol (2012) 169:57-69. doi:10.1111/j.1365-2249.2012.04588.x
10. Modell F, Puente D, Modell V. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies. Immunol Res (2009) 44(1-3):132-49. doi:10.1007/s12026-008-8092-3
11. Gardulf A, Björvell H, Gustafson R, Hammarström L, Smith CI. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol (1993) 92:200-4. doi:10.1111/j.1365-2249.1993.tb03380.x
12. Chapel HM. Hypogammaglobulinaemia and replacement therapy. Q J Med (1993) 86:136-7.
13. Gardulf A, Nicolay U, Math D, Asensio O, Bernatowska E, Böck A, et al. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol (2004) 114:936-42. doi:10.1016/j.jaci.2004.06.053
14. Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet (1995) 345:365-9. doi:10.1016/S0140-6736(95)90346-1
15. Bousfiha AA, Jeddane L, Ailal F, Al-Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol (2013) 33:1078-87. doi:10.1007/s10875-013-9901-6
16. Buckley R. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol (2004) 22:625-55. doi:10.1146/annurev.immunol.22.012703.104614
17. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency (SCID) in the neonatal period leads to superior thymic output and improved survival. Blood (2002) 99:872-8. doi:10.1182/blood.V99.3.872
18. Brown L, Xu-Bayford J, Allwood Z, Slatter M, Cant A, Davies EG, et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood (2011) 117:3243-6. doi:10.1182/blood-2010-08-300384
19. Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol (2005) 115:391-8. doi:10.1097/MOP.0b013e32834cb9b0
20. Kwan A, Church JA, Cowan MJ, Agarwal R, Kapoor N, Kohn DB, et al. Newborn screening for severe combined immunodeficiency and T cell lymphopenia in California: results of the first two years. J Allergy Clin Immunol (2013) 132:140-50. doi:10.1016/j.jaci.2013.04.024
21. Gaspar HB, Hammarström L, Mahlaoui N, Borte M, Borte S. The case for mandatory newborn screening for severe combined immunodeficiency (SCID). J Clin Immunol (2014) 34:393-7. doi:10.1007/s10875-014-0029-0
22. Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA (2014) 312(7):729-38. doi:10.1001/jama.2014.9132
23. Available from: http://www.rare-diseases.eu
24. UKPIN: UK Primary Immunodeficiency Network [Internet]. UKPIN (2014) [cited 2014 Aug 07]. Available from: www.ukpin.org.uk
25. DH Partnerships for Children, Families and Maternity/CNO Directorate (UK). Transition: Moving on Well. A Good Practice Guide for Health Professionals and Their Partners on Transition Planning for Young People with Complex Health Needs or a Disability [Internet]. NIH Publication. (2008) [cited 2014 Aug 07]. 81 p. Available from: http://www.bacdis.org.uk/policy/documents/transition_moving-on-well.pdf
26. Keller M, Glessner J, Resnick E, Perez E, Chapel H, Lucas M, et al. Burden of copy number variation in common variable immunodeficiency. Clin Exp Immunol (2014) 177:269-71. doi:10.1111/cei.12255
27. Orange JS, Glessner JT, Resnick E, Sullivan KE, Lucas M, Ferry B, et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol (2011) 127(6):1360-7. doi:10.1016/j.jaci.2011.02.039
28. CEREDIH: Le Centre de Référence Déficits Immunitaires Héréditaires [Internet]. Paris: CEREDIH (2014) [cited 2014 Sep 04]. Available from: https://www.ceredih.fr/
29. CEREDIH: The French PID Study Group. The French national registry of primary immunodeficiency diseases. Clin Immunol (2010) 135:264-72. doi:10.1016/j.clim.2010.02.021
30. UK Department of Health. Demand Management Plan for Immunoglobulin Use [Internet]. London: Department of Health (2008) [cited 2014 Aug 07]. 11 p. Available from: http://www.ivig.nhs.uk/documents/Demand_Management_Plan_SECOND_EDITION.pdf
31. ESID: European Society for Immunodefiencies [Internet]. ESID [cited 2014 Aug 07]. Available from: http://esid.org/
32. USIDNET. A Program of IDF. (2014) [cited 2014 Aug 07]. Available from: http://usidnet.org/usidnet-registry/publications
33. Sullivan KE, Puck JM, Notarangelo LD, Fuleihan R, Caulder T, Wang C, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol (2014) 34:428-35. doi:10.1007/s10875-014-0028-1
34. Parvaneh N, Casanova JL, Notarangelo LD, Conley ME. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol (2013) 131:314-23. doi:10.1016/j.jaci.2012.11.051
35. Jeffrey Modell Foundation. Global PI Village [Internet]. Jeffrey Modell Foundation [cited 2014 Aug 07]. Available from: http://www.info4pi.org/jmf/
36. Available from: http://www.irdirc.org
37. International Patient Organisation for Primary Immunodeficiences (IPOPI) [Internet]. [cited 2014 Aug 7]. Available from: http://www.ipopi.org/
38. National Member Organisations of IPOPI [Internet]. [cited 2014 Aug 07]. Available from: http://www.ipopi.org/index.php?page=member-organisations
39. IPOPI Immunoglobulin list [Internet]. IPOPI [cited 2014 Aug 07]. Available from: http://www.ipopi.org/index.php?page=immunoglobulin-countries
40. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol (2010) 125:1354-60. doi:10.1016/j.jaci.2010.02.040
41. Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the American academy of allergy, asthma and immunology. J Allergy Clin Immunol (2012) 130:1-24. doi:10.1016/j.jaci.2012.07.002
42. Gardulf A, Nicolay U. Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies. Curr Opin Allergy Clin Immunol (2006) 6:434-42. doi:10.1097/01.all.0000246619.49494.41
43. World Health Organization. 18th WHO Model List of Essential Medicines [Internet]. (2013) [cited 2014 Aug 7]. Available from: http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1
44. World Health Organization. 4th WHO Model List of Essential Medicines for Children [Internet]. (2013) [cited 2014 Aug 7]. Available from: http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1
45. Brennan VM, Salomé-Bentley NJ, Chapel H. Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin Exp Immunol (2003) 133:247-51. doi:10.1046/j.1365-2249.2003.02199.x
46. Espanol T, Prevot J, Drabwell J, Sondhi S, Olding L. Improving current Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and treatment views [Internet]. Patient Prefer Adherence (2014) 8:621-9. doi:10.2147/PPA.S60771
47. Obenga G, Mahlaoui N, Launay O. Recommandations vaccinales chez les patients atteints de déficit immunitaire héréditaire [Internet]. Centre de Référence Déficits Immunitaires Héréditaires (2009) [cited 2014 Aug 07]. 7 p. Available from: http://www.ceredih.fr/documents/Recos_Vaccins_20091113.pdf
48. Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol (2014) 133(4):1134-41. doi:10.1016/j.jaci.2014.02.028
49. Shearer WT, Fleischer TA; For the Medical Advisory Committee of the Immune Deficiency Foundation. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol (2014) 133:961-6. doi:10.1016/j.jaci.2013.11.043
50. Costa-Carvalho BT, Grumach AS, Franco JL, Espinosa-Rosales FJ, Leiva LE, King A, et al. Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice. J Clin Immunol (2014) 34:10-22. doi:10.1007/s10875-013-9954-6
51. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Consensus panel for the diagnosis and management of primary antibody deficiencies. BMJ (1994) 308:581-5. doi:10.1136/bmj.308.6928.581
52. Spickett GP, Askew T, Chapel HM. Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases. Qual Health Care (1995) 4:263-8. doi:10.1136/qshc.4.4.263
53. Gathmann B, Binder N, Ehl S, Kindle G; ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol (2012) 167:479-91. doi:10.1111/j.1365-2249.2011.04542.x